Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
May 2026: investigative outlet Investico alleged Biotronik ignored reports for years of problems with its defibrillator leads causing erroneous shocks; Biotronik firmly denies any wrongdoing and says nothing is wrong with its product.
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches, cyber incidents or regulator action involving Biotronik found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
Jan 2025: Germany's BfArM published a Biotronik field safety notice for its Pulsar-35 implant. May 2026 media reports alleged defibrillator lead problems (denied by Biotronik); HSH found no related regulator action.
Contract delivery, go-lives, terminations and disputes.
No notable go-lives, troubled implementations, terminations or customer disputes involving Biotronik found in HSH's search of the last 24 months.